Celine Halioua, the founder of Loyal, a biotechnology company developing a potential longevity drug for dogs, represents a growing trend in the pet-longevity market, where the intersection of human desires for longer pet lives and advancements in canine health sciences have led to significant investments, promising treatments, and an exploration of the implications for human aging research. #DogLongevity #PetCare #Biotechnology #US #TX #CA #UK
What if You Could Give Your Dog a Longer Life?